Extendicare Stock Forward View - Price Action Indicator
| EXE Stock | CAD 25.50 -0.61 -2.34% |
This page provides Price Action Indicator reference data for Extendicare, calculated from historical daily prices. The forecast output and associated deviation metrics are shown for informational use.
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997. Extendicare's Price Action Indicator reference data is provided for informational and analytical purposes and does not constitute a trading recommendation. Price Action Indicator Analysis Today
Extendicare has current Price Action Indicator of -0.49. Price Action indicator evaluates an asset for a given trading period using the following formula: ((close - open) + (close - high) + (close - low)) / 2. This indicator is consistent with the interpretation of Japanese candlestick patterns.| Previous Price Action Indicator | Price Action Indicator | Trend |
| -0.48 | -0.49 |
| Volatility | Backtest | Information Ratio |
Extendicare Trading Date Momentum
| On March 21 2026 Extendicare was traded for 25.50 at the closing time. The maximum traded price for the trading interval was 26.15 and the lowest daily price was 25.23 . There was no trading activity during the period. Lack of trading volume on 21st of March 2026 did not affect price variability. The overall trading delta to the closing price today is 2.31% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare Extendicare to competition |
Other Forecasting Options for Extendicare
The price movement of Extendicare is a central concern for all potential investors, regardless of their level of expertise. Extendicare Stock price charts can be difficult to interpret due to the noise present in the data.Extendicare Related Equities
The following equities are related to Extendicare within the Health Care space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing Extendicare against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
| Risk & Return | Correlation |
Extendicare Market Strength Events
Market strength indicators applied to Extendicare stock help investors assess the relative momentum and resilience of the security in different market environments. By using these indicators, traders can make more informed decisions about when to buy or sell Extendicare.
Extendicare Risk Indicators
Risk indicator analysis for Extendicare is essential for accurately projecting its future price trajectory. By identifying the level of risk embedded in Extendicare's investment, investors can make informed decisions about position sizing and risk mitigation.
| Mean Deviation | 1.36 | |||
| Semi Deviation | 1.25 | |||
| Standard Deviation | 1.99 | |||
| Variance | 3.98 | |||
| Downside Variance | 1.97 | |||
| Semi Variance | 1.56 | |||
| Expected Short fall | -1.69 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Extendicare
A coverage review of Extendicare shows when the security is attracting above-average attention from contributors and market observers. The practical risk is that faster visibility can increase both interest and skepticism at the same time.
Other Macroaxis Stories
Macroaxis publishes story content for a diverse readership that includes finance students, independent investors, money managers, and market-focused operating teams. What connects that audience is a focus on building stronger portfolios through better research, risk awareness, and comparative analysis.
Story Categories
Currently Trending Categories
Extendicare Short Properties
A short-interest review of Extendicare provides context for understanding whether skepticism in the market is becoming more influential. A disciplined short-interest review can make timing decisions more informed under rising skepticism.
| Common Stock Shares Outstanding | 86.8 M | |
| Cash And Short Term Investments | 349.2 M |
More Resources for Extendicare Stock Analysis
Other Information on Investing in Extendicare Stock
Financial ratios represent how different financial values are linked for Extendicare. They reflect how financial results tie into valuation measures. The format ensures financial data remains comparable across time periods. All values are presented as reference data based on the latest available reporting.